Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against Heartware International Inc. (“Heartware” or the “Company”) (Nasdaq: HTWR). Investors who purchased or otherwise acquired shares between June 10, 2014 and January 11, 2016, (the “Class Period”), are encouraged to contact the firm in advance of the March 22, 2016, lead plaintiff motion deadline.

If you are a shareholder who suffered a loss during the Class Period, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the complaint, the U.S. Food and Drug Administration (FDA) issued a Warning Letter identifying several regulatory failures at the Company's sole manufacturing facility. The Company had falsely assured the investing public that those issues had been remedied, and claimed that those issues posed no threat to the approval of MVAD.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Goldberg Law PC, Los AngelesMichael Goldberg, Esq., 800-977-7401Brian Schall, Esq., 800-977-7401info@goldberglawpc.com

Heartware International, Inc. (MM) (NASDAQ:HTWR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Heartware International, Inc. (MM) Charts.
Heartware International, Inc. (MM) (NASDAQ:HTWR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Heartware International, Inc. (MM) Charts.